Clinical T
This input is used for staging
Notes
**Note 1:** Assign 88 for in situ cases (behavior code /2). TNM does not include an in situ category for NET rectum tumors. **Note 2:** Ignore intraluminal extension to adjacent segment(s) of colon/rectum or to the ileum from the cecum; code depth of invasion or extracolonic spread as indicated. **Note 3:** Tumor size must be known to assign a value of T1 or T2. You may use a physician’s statement of the T (sub)category if this is the only information in the medical record. * If the tumor appears to be in the T1 or T2 (sub)categories, but no size or category is specified, assign TX **Note 4:** Assign the appropriate T (sub)category (T1, T2) based on the tumor size for the following descriptions Invasive tumor confined to mucosa, NOS including intramucosal, NOS Invades lamina propria, including lamina propria in the stalk of a polyp Invades submucosa (superficial invasion), including submucosa in the stalk of a polyp Confined to and not through the muscularis mucosae, including muscularis mucosae in the stalk of a polyp Confined to colon, NOS Localized, NOS **Note 5:** Assign T4 for tumor with macroscopic adhesions to other organs or structures and for pathologically confirmed tumor in adhesions. * If no tumor is present in adhesions upon microscopic examination, assign the appropriate T category to describe the microscopically confirmed depth of tumor invasion for these casesNAACCR Item
NAACCR #940Clinical T | Clinical T Display | Description | Registrar Notes |
---|---|---|---|
cX | cTX | Primary tumor cannot be assessed | Clinical classification criteria met, evaluation done: Physician unable to assess T Extension cannot be determined Tumor size (TS) unknown for T categories where TS needed to determine T Physician assigns cTX, no other information available to determine T |
c0 | cT0 | No evidence of primary tumor | |
c1 | cT1 | Tumor invades lamina propria or submucosa and is no greater than 2 cm in size | Note: T1 has subcategories of T1a and T1b. Assign T1 only when there is no information available to assign one of the subcategories Stated as T1 [NOS] |
c1A | cT1a | Tumor less than 1 cm in size | Stated as T1a |
c1B | cT1b | Tumor 1-2 cm in size | Stated as T1b |
c2 | cT2 | Tumor invades muscularis propria OR Is greater than 2 cm in size |
Muscularis propria invaded Stated as T2 |
c3 | cT3 | Tumor invades subserosa, or non-peritonealized pericolic or perirectal tissues | Extension through wall, NOS Invasion through muscularis propria or muscularis, NOS Perimuscular tissue invaded Subserosal tissue/(sub)serosal fat invaded Transmural, NOS For rectum (C209): Tumor invading through muscularis propria with intraluminal extension to colon and/or anal canal/anus Adjacent (connective) tissue: For all sites: Perirectal fat For rectosigmoid (C199): Mesentery (including mesenteric fat, mesocolon) Pericolic fat For rectum (C209): Rectovaginal septum Fat, NOS Stated as T3 |
c4 | cT4 | Tumor perforates peritoneum OR Invades other organs |
Invasion of/through serosa (mesothelium) (visceral peritoneum) Adherent to other organs or structures, NOS For both rectum and rectosigmoid sites: Bladder Cul de sac (rectouterine pouch) Ovary(ies) Pelvic wall/pelvic plexuses Prostate Skeletal muscle of pelvic floor Uterus Vagina For rectosigmoid (C199): Small intestine Colon via serosa Fallopian tube(s) Ureter(s) For rectum (C209): Anal canal/anus extraluminally Bone(s) of pelvis Cervix Ductus deferens Perineum, perianal skin Rectovesical fascia for males only Sacrum Sacral plexus Seminal vesicle(s) Urethra Further contiguous extension Stated as T4 |
88 | 88 | Not applicable | In situ case but no pTis is defined by TNM Death certificate only (DCO) case |
<BLANK> | BLANK | See Registrar Notes | Clinical classification criteria not met Clinical classification criteria met, evaluation done: No information about diagnostic workup Results not documented in record Clinical evaluation of primary tumor not done or unknown if done Tumor first detected on surgical resection (no clinical workup) Evidence of metastatic disease [(cM1) or (pM1)], no other workup Only Clinical Stage Group documented (no T, N, or M information available) |